AGP Executive Report
Last update: an hour agoRobotics: China has blocked SoftBank’s $5.4 billion purchase of ABB’s robotics business. ABB and SoftBank are reportedly weighing a carve-out of the Chinese operations, a key market for ABB, as Beijing tightens scrutiny of strategic technology deals. Medical Research: ETH Zurich researchers have demonstrated a wireless, battery-free implant that uses electrochemistry to reduce blood sugar in diabetic mice. Human trials are still years away. Swiss Startups: Dental-tech company vVardis is targeting a US IPO that could value it at up to $4.4 billion. Gene Therapy: Novartis has reported nine cases of tumors in children treated with its Zolgensma gene therapy, prompting renewed attention to the treatment’s safety.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.